Incannex Healthcare Inc. (NASDAQ:IXHL – Get Free Report) was the recipient of a significant increase in short interest during the month of July. As of July 15th, there was short interest totalling 14,000 shares, an increase of 100.0% from the June 30th total of 7,000 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average trading volume of 25,600 shares, the short-interest ratio is presently 0.5 days.
Incannex Healthcare Price Performance
IXHL traded up $0.01 on Friday, reaching $2.17. The company had a trading volume of 12,046 shares, compared to its average volume of 154,332. Incannex Healthcare has a 1 year low of $0.80 and a 1 year high of $12.68. The stock has a 50-day moving average price of $2.87 and a 200-day moving average price of $3.30.
Incannex Healthcare (NASDAQ:IXHL – Get Free Report) last announced its earnings results on Wednesday, May 15th. The company reported ($0.38) EPS for the quarter.
Institutional Investors Weigh In On Incannex Healthcare
About Incannex Healthcare
Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.
See Also
- Five stocks we like better than Incannex Healthcare
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- What is a Dividend King?
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- 3 REITs to Buy and Hold for the Long Term
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for Incannex Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Incannex Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.